Alcohol is a major risk factor for oesophageal squamous cell carcinoma (OSCC), the most prevalent histological subtype of oesophageal cancer (OC) worldwide. The metabolism of alcohol is regulated by specific enzymes whose activity and expression is influenced by genetic polymorphisms. We conducted a systematic review of current epidemiological evidence of the relationship between alcohol intake and OC risk, including the role of tobacco smoking and functional polymorphisms of alcohol dehydrogenases (ADHs) and aldehyde dehydrogenases (ALDHs). Potential biological mechanisms underlying oesophageal carcinogenesis are also discussed. Frequency and intensity of alcohol intake have been consistently associated with an increased risk of OSCC in regions with low and high incidence of the disease. The highest risk was reported among tobacco smokers, whereas the association between alcohol and OSCC risk was weak in the absence of tobacco use. The ADH1B, ADH1C and ALDH2 gene polymorphisms influence the risk of OSCC through modulation of acetaldehyde metabolism and propensity to alcohol intake. These functional variants may be suitable proxies of alcohol exposure for use in Mendelian randomization studies if complemented by reported alcohol intake data. Recent epidemiological and experimental studies investigating the role of alcohol consumption in OC development have implicated the microbiome as a new promising avenue for research, which entail novel potential mechanisms of alcohol-related oesophageal carcinogenesis. Microbial communities associated with alcohol consumption might be used as biomarkers to raise the potential of intervening among susceptible individuals.
Introduction
Oesophageal cancer (OC) is the eighth most common cancer worldwide causing more than 400 000 deaths every year, and over 80% of the cases and the deaths occur in developing regions such as Eastern Asia and Southern and Eastern Africa (1) .
Cancer of the oesophagus exists as two main histological subtypes, oesophageal squamous cell carcinoma (OSCC) and oesophageal adenocarcinoma (OAC), which exhibit distinct etiologies ( Figure 1 ) (2) . Ecological and retrospective studies in Europe found that alcohol and tobacco use are positively and independently correlated with the incidence and mortality rates of OSCC (3, 4) . The significant association between alcohol intake and OSCC risk has also been reported in prospective investigations (5, 6) and meta-analyses of epidemiological studies (7, 8) . Conversely, both retrospective (9) (10) (11) (12) and prospective (5, 6) studies consistently reported a lack of association with OAC risk, even at high doses of alcohol intake. On the other hand, the high burden of OAC in Western societies is mostly related to obesity, gastro-oesophageal reflux disease and Barrett's oesophagus (13) . Tobacco use has also been associated with OAC, although with less pronounced effects than for OSCC (14) . Several other factors including genetic polymorphisms, socioeconomic disparities and dietary factors may contribute to differences in the occurrence of OC across populations (15, 16) .
In humans, ingested alcohol is primarily absorbed from the small intestine into the liver and metabolized by two major groups of enzymes named alcohol dehydrogenases (ADHs) and aldehyde dehydrogenases (ALDHs) (17) . In the cytosol of hepatocytes, ADHs catalyse the oxidation of ethanol to acetaldehyde, which is further oxidized to acetate by ALDHs in the mitochondria ( Figure 2 ). Acetaldehyde has been classified as carcinogenic to humans (IARC Group 1) and recognized as an important determinant of upper aerodigestive tract cancer (18) . The accumulation of acetaldehyde in human tissues is dependent on the balance of the rate of its formation from alcohol by ADHs and the rate of its removal by ALDHs (19) . A review of case-control studies on genetic polymorphisms of alcohol metabolizing enzymes and OSCC risk shows significant associations between the lowactivity ADH1B and ALDH2 genotypes and the risk for OSCC in East Asian heavy drinkers (20) . The genetic variability associated with heterogeneity of the activity of alcohol metabolizing enzymes may result in a larger window of exposure to acetaldehyde among medium/heavy alcohol drinkers (21) . In recent years, the genome-wide association study (GWAS) approach has emerged as a powerful tool to identify genetic variants of modest effect size that may not be recognized in candidate gene studies (22) . If a causal association between the polymorphism of interest and alcohol intake is established, the genetic variant can be used as a proxy for acetaldehyde exposure to assess the association between alcohol use and OSCC risk without the potential confounding introduced by other environmental risk factors (23) .
The gut microbiome, which refers to the total population of microbial organisms found in the gastrointestinal tract, plays a key role in the digestion and assimilation of food and protection against pathogens (24, 25) . Alcohol intake may lead to alteration of microbial composition or activity contributing to the development of cancer (26) . However, little is known about the effect of chronic exposure to alcohol on oesophageal carcinogenesis through changes in the microbiome.
In this systematic review, we summarize the epidemiological evidence of the association between alcohol intake and the risk of OSCC, including the role of tobacco smoking and functional polymorphisms of the main alcohol metabolizing enzymes. Established mechanisms of alcohol-related carcinogenesis and gastrointestinal microbiome as an emerging area of research underlying potential novel biochemical pathways are described. In addition, we discuss the Mendelian randomization approach as a powerful tool to examine the causal relationship between alcohol and oesophageal carcinogenesis. Due to the consistently reported lack of association between alcohol intake and OAC risk in different populations (5, 6, (9) (10) (11) (12) , the present review is mainly focused on the squamous cell carcinoma subtype of OC.
Data sources and methods
A systematic evaluation of the existing epidemiological evidence of the association between alcohol intake and OC risk was carried out, including the effect modification of tobacco smoking and genetic polymorphisms of major alcohol metabolizing enzymes. Epidemiological studies published in English were searched up to November 2016 in MEDLINE and EMBASE databases. The main terms used in the search were 'oesophageal cancer/adenocarcinoma/squamous cell carcinoma', 'alcohol consumption', 'alcohol metabolism', 'acetaldehyde', 'tobacco smoking', 'genetic polymorphism', 'alcohol dehydrogenase' and 'aldehyde dehydrogenase'. All selected articles were reviewed, and relevant publications were selected if (i) carried out in humans with a case-control or prospective study design, (ii) evaluated the association between alcohol intake (any alcoholic beverages) and OSCC risk, (iii) assessed the modifying effect of tobacco smoking or genetic polymorphisms of alcohol metabolizing enzymes and (iv) reported measures of association (i.e. odds ratio, relative risk) with related confidence intervals. Data from recent metaanalyses and pooled analysis were also included. Studies that evaluated tumour progression during alcohol consumption, as well as somatic mutations or genetic prognostic markers of OC, were excluded. The effect of gender and age on the association between alcohol and OC risk are outside the scope of this review. An independent search was conducted for epidemiological studies on the association between the human microbiome, alcohol consumption and the occurrence of OC or premalignant oesophageal conditions (i.e. Barrett's oesophagus, oesophagitis). Studies cited in the original papers were also examined.
The nomenclature of polymorphisms and genes followed the HGNC Database of Human Gene Names (27) . A polymorphism designation starting with numbers refers to a nucleotide position, and subsequent letters indicate the nucleotide change (i.e. 313A>G). A polymorphism designation that starts with letters indicates an amino acid substitution, and the following number is the codon position (i.e. Ala113Val). The nomenclature for the polymorphic variants mentioned in this review is consistent with previous literature in the field. A summary of the updated nomenclature for these variants using the most recent genome annotation (GRCh38) adopted by the Human Genome Variation Society (28) is provided in Table 1 .
Alcohol consumption and OC
Intensity and duration of alcohol use have been consistently associated with the risk of OSSC in case-control studies conducted in Eastern Asian populations (29) (30) (31) analysis of four case-control studies including a total of 789 OSCC cases from Western countries (USA and Sweden) and Uruguay reported an increased risk among individuals with the highest level of alcohol intake [odds ratio (OR) = 2.34; 95% confidence interval (CI) = 1.22-3.45] compared to those with the lowest level (32) . Similar findings were reported in prospective studies, which measure dietary intakes at recruitment and are thus less prone to assessment bias and reverse causation than case-control studies (33) . A prospective investigation including 97 incident cases of OSCC from the USA found that heavy alcohol drinkers (>3 drinks/day) were at increased risk [hazard ratio (HR) = 4.93; 95% CI = 2.69-9.03] of OSCC compared with moderate drinkers (≤1 drinks/day) (6). These findings were confirmed in two population-based cohort studies in China (68 OSCC cases) and Europe (107 OSCC cases), where the risk was significantly higher among regular alcohol drinkers (HR = 2.02, 95% CI = 1.31-3.12) and subjects who consumed more than 30 g/ day of alcohol (HR = 4.61; 95% CI = 2.24-9.50), respectively, compared with non-drinkers (5, 34) . Despite the prospective study design and the long duration of follow-up, these studies had low statistical power to detect moderate main effects or potential interactions. A larger cohort study in Linxian, China, including 1958 OSCC cases found a significant association between ever cigarette smoking and OSCC (OR = 1.34; 95% CI = 1.16-1.54), but failed to detect an increased risk associated with alcohol intake (OR = 0.92; 95% CI = 0.82-1.03). The authors concluded that the null association between alcohol consumption and OSCC risk was likely due to the low proportion of alcohol drinkers in this rural area of China (35) .
A recent meta-analysis of 13 prospective and 41 case-control studies including 14 318 OSCC cases found a significant association between alcohol intake and OSCC, with a relative risk (RR) of 1.26 (95% CI = 1.06-1.50), 2.23 (95% CI = 1.87-2.65), and 4.95 (95% CI = 3.86-6.34) among light (≤12.5 g/day), moderate (≤50 g/day) and heavy (>50 g/day) alcohol drinkers, respectively, compared with non-drinkers and occasional drinkers. A stronger association was observed for case-control studies than for cohort studies, although there was no significant heterogeneity between the two study designs (P-heterogeneity = 0.157). Furthermore, light alcohol consumption was significantly associated with the risk of OSCC in Asian populations (RR = 1.54; 95% CI = 1.18-2.00), but not in other ethnicities (7) . There is evidence of a J-shaped relationship between alcohol intake and OSCC risk (6, 12, 36) . For example, the Million Women Study's reported a significantly increased risk of the non-adenocarcinoma subtype of OC among non-drinkers (RR = 1.56; 95% CI = 1.29-1.89) and women drinking 7-14 drinks/week (RR = 1.56; 95% CI = 1.26-1.94) or more (RR = 2.99; 95% CI = 2.24-4.00) compared to those drinking <2 drinks/week (36) . However, a recent meta-analysis of 13 cohort studies showed that alcohol was monotonically positively related to OSCC risk (7) . Further studies that are of sufficient sample size to delineate associations between OSCC risk in non-drinkers and light drinkers would be informative.
Joint effect of alcohol consumption and smoking on OC
Alcohol consumption and smoking are often complementary behaviours, and it is difficult to separate their individual effects on an outcome in observational studies (38) . Prospective investigations conducted in different ethnic groups provide support for the independent role of alcohol and tobacco use in the etiology of OSCC (5, 6, 34) . However, a multiplicative interaction between the two risk factors has been consistently reported in several retrospective studies (12, 30, 31, (39) (40) (41) (42) (43) . A large case-control study of OSCC including 1520 Chinese cases from Jiangsu Province found that individuals who smoked and drank heavily (≥40 cigarettes/day and ≥500 ml of alcohol/week) had a 7.32-fold (95% CI = 4.58-11.7) higher risk compared with never users of tobacco and alcohol. Heavy smoking among never drinkers significantly increased the risk of OSCC (OR = 2.45; 95% CI = 1.20-4.96), whereas a non-significant increment in risk (OR = 1.38; 95% CI = 0.97-1.98) emerged among heavy alcohol drinkers who never smoked (30) . On the other hand, a prospective study in the Netherlands including 107 OSCC cases reported a significantly increased risk associated with high alcohol intake (>15 g/day; HR = 3.74; 95% CI = 1.25-11.20) compared with low intake (≤5 g/day) among never smokers, and the risk was approximately two-fold higher (HR = 8.05; 95% CI = 3.89-16.60) among current smokers who consumed the same amount of alcohol (5) .
A meta-analysis of three case-control studies and two prospective studies including a total of 430 OSCC cases reported a non-significant increase in risk associated with ever-alcohol use and never-tobacco use (OR = 1.22; 95% CI = 0.81-1.81), while ever use of both alcohol and tobacco was associated with a significantly higher risk (OR = 3.28; 95% CI = 2.11-5.08) compared with never-use (44) . This meta-analysis was limited to studies conducted in Asian populations, and it is unclear whether similar association patterns occur in other ethnicities. However, these findings are consistent with the results from a large pooled analysis of case-control studies in Caucasians and Latin Americans including a total of 10 244 cases with head and neck cancer, in which no significant association between alcohol intake and head and neck cancer risk was reported among non-smokers (45).
Alcohol-related mechanisms of oesophageal carcinogenesis
Several mechanisms of alcohol-induced carcinogenesis have been proposed, including the effect of acetaldehyde, oxidative stress and chronic inflammation (46) . Chronic exposure to acetaldehyde can lead to the formation of DNA adducts (47, 48) , and induces chromosomal aberrations and sister chromatid exchanges in human lymphocytes (49, 50) . Acetaldehyde may also inhibit enzymes involved in DNA repair, and ultimately lead to impaired DNA damage response (51) . Chronic alcohol consumption results in a dose-dependent induction of cytochrome P450 2E1 (CYP2E1) in the human oesophagus (52) , which contributes to the hepatic oxidation of ethanol to acetaldehyde. CYP2E1 also produces high quantities of reactive oxygen species that may cause DNA damage through oxidative stress, inflammation and lipid peroxidation (53, 54) . Other pathological effects associated with alcohol include tumour promotion activity (55), overproduction of mitogen-activated protein kinases (56) , impaired expression of retinol (57) or insulin-like growth factors (58) and immunosuppression (59); however, further experimental studies are needed to clarify these potential mechanisms.
Increasing evidence suggests that alcohol may induce carcinogenesis through aberrant DNA methylation (60) . Alcohol and tobacco use was found to induce global DNA hypomethylation and promoter region hypermethylation in alcohol-associated cancers, including OSCC, which may affect the expression of genes involved in cell cycle, DNA damage repair and tumour suppression (61, 62) . Despite alcohol and tobacco use are complementary behaviours, a genome-wide methylation study on lymphoblast DNA derived from 165 women found no difference in smoking intensity between the alcohol use groups and controlling for smoking did not modify the association between alcohol intake and DNA methylation changes (63) . These findings suggest that tobacco smoking and alcohol consumption may have distinct effects on DNA methylation.
Recent evidence suggested that chronic alcohol consumption is associated with an imbalance of the intestinal microbiota composition and/or metabolic function, known as dysbiosis, that leads to systemic inflammation and tissue damage (64) (65) (66) . Based on these findings, it is plausible that the oesophageal microbiome might play a role in the development of alcoholrelated OSCC. However, no study to date has investigated the microbiome composition in relation to OSCC development.
Several biological mechanisms have been proposed to explain the interaction between alcohol and tobacco use in oesophageal carcinogenesis. Ingested alcohol may cause local irritation of the oesophagus and act as a solvent for tobaccorelated carcinogens, facilitating their absorption through the oesophageal mucosa (67) . Chronic smoking modifies the oral flora leading to a higher proportion of aerobic bacteria and yeasts capable of generating acetaldehyde from ethanol (68) . Furthermore, tobacco-derived carcinogens have an inhibitory effect on ALDH activity, thus resulting in the less efficient removal of acetaldehyde from the oral cavity (69) . It follows that the oesophageal mucosa of smokers who drink alcohol may be exposed to higher salivary acetaldehyde levels compared with non-smokers. The alcohol-induced expression of CYP2E1 in the oesophagus may lead to local enhanced metabolic activation of tobacco-derived carcinogens (53) . Cigarette smoke also contains high amounts of acetaldehyde that can be directly absorbed by the oesophageal mucosa and add further carcinogenic effect to the ethanol-derived acetaldehyde (70, 71) . Thus, the joint effect of alcohol and tobacco use on the increased risk of OSCC relies on strong biological plausibility.
Microbiota and OC
Recent epidemiological studies provide evidence of the existence of a complex microbial community in the distal human oesophagus, made up of approximately 140 bacterial species grouped in six phyla (Firmicutes, Bacteroides, Actinobacteria, Proteobacteria, Fusobacteria, and TM7) (72) . Cross-sectional studies based on bacterial 16S rRNA gene data found significant differences in the bacterial composition between the normal oesophagus and reflux disorders that precede OAC, such as Barrett oesophagus and reflux esophagitis. These studies demonstrated the transformation of the microbiome from a predominance of grampositive bacteria to mostly gram-negative bacteria (73, 74) . Other studies reported a significant increase in bacteria from the phylum Campylobacter (75, 76) , which has been associated with several gastrointestinal diseases including colon cancer (77, 78) . Cultural analyses on OC tissues reported quantitative and qualitative changes in the oesophageal microbiota compared to healthy tissues (79) (80) (81) . However, these studies did not distinguish between histological subtype (OAC and OSCC) and suffer from the limitations associated with the culture-based approach (73) . On the other hand, a study on the microbiome of patients with OAC did not detect significant differences compared to control individuals (75) . No study to date has investigated the microbiome composition in OSCC tissue. However, cross-sectional studies that used gastrointestinal samples as proxies for oesophageal microbiome reported significantly altered microbial composition and abundance in patients with oesophageal squamous dysplasia compared to control individuals (82, 83) .
Several cross-sectional investigations found that chronic alcohol consumption is associated with an imbalance of the intestinal microbiota composition and/or metabolic function in both rodent models (84, 85) and humans (64) (65) (66) 86) . Compared to healthy control individuals, alcoholics had significantly reduced levels of Bacteroidetes, which generally have beneficial effects in the gut (87) , and increased levels of Proteobacteria, a major phylum of gram-negative pathogenic bacteria associated with intestinal bacterial imbalance (88) .
An imbalance of the intestinal microbiota, known as dysbiosis, may contribute to the pathogenesis of OC by altering the intestinal barrier integrity, resulting in hyperpermeability and translocation of pathogenic gram-negative-derived bacterial products (i.e. lipopolysaccharide and peptidoglycan) from the intestinal lumen into systemic circulation, a condition known as gut leakiness (87, 88) . Increased intestinal permeability and gut leakiness have been well described in alcoholics, which correlate with high levels of endotoxin in the blood (64) . Exposure to these bacterial-derived pro-inflammatory products in alcoholics activates specific inflammatory pathways that may cause inflammation in the oesophagus and contribute to the direct effects of alcohol on oesophageal carcinogenesis (91, 92) . Thus, dysbiosis of the oesophageal microbiome associated with increased plasma levels of gut-derived bacterial products could be specifically relevant among alcohol drinkers (93, 94) . Based on these findings, it is plausible that the bacteria present in the oesophagus and/or the metabolites produced by the bacteria might contribute to the indirect toxicity of alcohol consumption and play a role in the development of alcohol-related OSCC.
Role of genetic polymorphisms in alcohol consumption and OC development Table 1 shows major functional polymorphisms within the ADH and ALDH loci that have been associated with changes in alcohol metabolism or alcohol consumption behaviour. Of note, the ADH1B*2 (rs1229984) and ALDH2*2 (rs671) genotypes occur at high frequency in Eastern Asian populations, while low variability at these polymorphic sites has been reported in Caucasians and Africans. On the other hand, the ADH1C*2 (rs698) allele is more frequently observed in Caucasians than Eastern Asians. A detailed description of the major genes involved in alcohol metabolism (Supplementary Table 1 
Candidate gene studies

ADH1B
A case-control study including 234 Japanese male cases reported a significantly increased risk of OSCC among individuals with the low-activity ADH1B*1/*1 (wild-type) genotype compared with carriers of the ADH1B*2 allele (rs1229984) among light (1-8.9 units/week), moderate (9-17.9 units/week) and heavy (≥18 units/week) alcohol drinkers. No significant association emerged among never/rare alcohol drinkers (95) . These findings are consistent with case-control studies conducted in Thailand (96), Taiwan (97, 98) and Jiangsu Province in China (99, 100) .
A case-control study including 406 cases from Taiwan found that tobacco smoking modified the interaction between the ADH1B polymorphism and alcohol use on the risk of OSCC. Among smokers, low-to-moderate alcohol drinkers (0.1-30 g/day) carrying the ADH1B*1/*1 genotype were at significantly higher risk than non-drinkers with the ADH1B*2 allele (OR = 2.9; 95% CI = 1.3-6.6), while no significant association was found among non-smokers (98) .
A protective effect of the ADH1B*2 allele on the risk of OSCC was also observed in a case-control study including 201 Mixed Ancestry cases from South Africa. The association was significant among alcohol drinkers (OR = 0.55; 95% CI = 0.33-0.94) and tobacco smokers (OR = 0.45; 95% CI = 0.24-0.84), while no evidence of association emerged among non-drinkers and former smokers. However, the proportion of non-drinkers and former smokers was very small, with low power to detect any potential association in these subgroups (101) .
ADH1C
The role of ADH1C gene polymorphism in oesophageal carcinogenesis has been poorly investigated and findings are contradictory. Case-control studies conducted in Asians and Caucasians reported either a positive (95,102), negative (103) or null (99) association between the ADH1C*2 allele and OSCC risk compared with the wild-type ADH1C*1/*1 genotype, and no consistent effect modification by alcohol or tobacco use was observed. A significantly high linkage disequilibrium (LD) (P < 0.001) was reported between the ADH1B and ADH1C gene polymorphisms in different ethnic groups (104) , and the association between ADH1C*2 and OSCC was masked by the independent effect of ADH1B*1/*1 on the occurrence of disease (95, 102) . Thus, variable LD patterns between populations could explain why different studies have produced inconsistent results, but an independent effect of ADH1C*2 on the risk of OSCC cannot be completely ruled out due to its suggested functionality.
ALDH2
Several case-control studies conducted in Japan (95), Thailand (96), Taiwan (97, 98) and Jiangsu Province in China (99,100) found the low-activity ALDH2*1/*2 (rs671) genotype to be significantly associated with an increased OSCC risk compared to carriers of the ALDH2*1/*1 wild-type genotype among alcohol drinkers, Hangzhou set + Jinan set. Table 2 . Continued while no significant associations emerged among non-alcohol consumers. Tobacco smoking was shown to modify the interaction between the ALDH2 polymorphism and alcohol use on the risk of OSCC in a case-control study including 406 Taiwanese cases. Among tobacco smokers, the joint effect of ALDH2*2 allele (*1/*2 + *2/*2) and alcohol consumption (0.1-30 g/day) conferred a significantly higher risk compared with non-drinkers carrying the ALDH2*1/*1 genotype (OR = 7.2; 95% CI = 3.7-14.1), while no significant association was observed among non-smokers (98).
Meta-analyses and pooled analyses
A recent meta-analysis of 18 case-control studies with a total of 8906 OC cases of Asian ancestry reported a 2.77-fold increased risk (95% CI = 2.14-3.58) associated with the wildtype ADH1B*1/*1 genotype compared with carriers of the variant allele (ADH1B*1/*2 or ADH1B*2*2), and the risk was highest among heavy alcohol drinkers (OR = 4.82; 95% CI = 3.50-6.64) and smokers (OR = 2.67; 95% CI = 1.89-3.45) (105) .
A pooled analysis of three case-control studies in European Caucasians and Latin Americans found a significant inverse association between either rs1229984 (ADH1B*2; OR = 0.34; 95% CI = 0.20-0.56) or rs1573496 (ADH7; OR = 0.45; 95% CI = 0.32-0.64) and the risk of OSCC. The intensity of alcohol use was associated with an increasing protective effect of either single nucleotide polymorphism (SNP), while little or no effect occurred among never drinkers. No significant difference in association was observed with regard to smoking status (104).
Genome-wide association studies
The first GWAS of OSCC was carried out on a total of 1070 Japanese cases and found significant associations with 10 SNPs located on chromosome 4q21-q23 (ADH) or 12q24 (ALDH). Among these variants, rs1229984 (ADH1B*1; OR = 1.79; P = 7.75 × 10 −24
) and rs671 (ALDH2*2; OR = 1.67; P = 3.27 × 10 −24 ) had a stronger and independent effect on the risk. Gene-environment interactions were found between rs1229984 and alcohol drinking (OR = 1.95; P = 0.045), as well as between rs671 and alcohol drinking (OR = 2.19; P = 8.30 × 10 −5 ) or tobacco smoking (OR = 1.90; P = 0.0044) (106) . These findings support the evidence from candidate gene studies that alcohol drinkers who exhibit the low-activity ADH1B and ALDH2 alleles are at higher risk of developing OSCC (95) (96) (97) (98) (99) (100) 105) .
A GWAS including a total of 8307 cases of Han Chinese descent identified three SNPs (rs11066015, rs2074356 and rs11066280) on chromosome 12q24 significantly associated with an increased risk of OSCC (ORs = 1.33-1.56; P from 5.07 × 10 −12 to 2.44 × 10 −31
). These variants were in high LD with each other (r 2 > 0.69), and only the association with rs2074356 remained significant at the genome-wide level after mutual adjustment. The risk associated with the three SNPs was more pronounced among alcohol drinkers (P-interaction from 6. ) and tobacco smokers (P-interaction from 0.043 to 0.001) (107) . An independent GWAS with 10 123 OSCC cases recruited from Jiangsu, Henan and Guangdong Provinces of China identified eight significantly associated SNPs (rs1042026, rs3805322, rs17028973, rs1614972, rs17033, rs1229977, rs1789903 and rs1893883; P from 1. ), with a markedly higher risk among alcohol drinkers compared with non-drinkers. Further, 15 SNPs located on 12q24, including three variants (rs11066015, rs2074356 and rs11066280) that were previously reported to interact with alcohol consumption to promote oesophageal carcinogenesis (107) , were significant in genealcohol interaction analyses (P-interaction from 1.42 × 10 −23 to 9.88 × 10 −5 ) (108). However, a GWAS from China that included 2115 OSCC cases found no significant association between the ADH1B and ALDH2 polymorphisms and OSCC risk in a population with very modest alcohol consumption (109) . This null finding highlights the relevance of alcohol exposure to convey OSCC risk in subjects carrying variants related to acetaldehyde metabolism.
A GWAS in European Caucasians including 8605 cases with upper aerodigestive tract cancer reported an inverse association between either rs1229984 (ADH1B*2; OR = 0.38; 95% CI = 0.24-0.59) or rs1573496 (ADH7; OR = 0.49; 95% CI = 0.36-0.66) and the risk of OSCC (110), thus supporting the findings from a previous case-control study in the same population (104). Significant heterogeneity was found for rs1229984 when stratified by alcohol consumption status (P-heterogeneity = 0.015); the reduced risk of OSCC associated with rs1229984 was significant among light (OR = 0.66; 95% CI = 0.55-0.79) and heavy (OR = 0.59; 95% CI = 0.49-0.70) alcohol drinkers, while no inverse association emerged among non-drinkers (OR = 1.18; 95% CI = 0.95-1.47). A positive association was also reported for rs4767364 (ALDH2; OR = 1.45; 95% CI = 1.24-1.69) and rs698 (ADH1C*2; OR = 1.17; 95% CI = 1.00-1.37); however, alcohol use did not influence the risk associated with either SNP (P-heterogeneity = 0.920 and 0.994, respectively) (110) . The variant rs4767364 at 12q24 was also significantly associated with OSCC risk in a small replication set of African Americans (P = 0.004) (110) , suggesting that genetic determinants of OSCC in European Caucasians may be extended to populations of non-European descent.
Mendelian randomization and alcohol exposure
Conventional epidemiological studies designed to investigate the association between alcohol consumption and OSCC risk may suffer from reverse causation, assessment bias and confounding by other lifestyle factors such as tobacco smoking and unhealthy dietary patterns (111) (112) (113) . To overcome these limitations, genetic polymorphisms that influence alcohol consumption behaviour may be used as surrogates of alcohol exposure and ultimately as indicators of the effect of different exposure levels on disease risk (114) .
A cross-sectional study in the Japanese population reported peak blood acetaldehyde levels post alcohol intake 18 and 5 times higher among heterozygotes or homozygotes, respectively, for the ALDH2*2 (rs671) null allele compared with ALDH2*1/*1 homozygotes (115), suggesting that the ALDH2 genotype is a good proxy for acetaldehyde exposure. A meta-analysis of seven case-control studies including a total of 905 OSCC cases from East Asian populations reported an inverse association between OSCC risk and ALDH2*2/*2 homozygosity (OR = 0.36; 95% CI = 0.16-0.80) compared with the ALDH2*1/*1 genotype, but a positive association for ALDH2*1/*2 heterozygosity (OR = 3.19; 95% CI = 1. 86-5.47 ). An increased risk of OSCC was observed for ALDH2*1/*2 among alcohol drinkers (OR = 7.07; 95% CI = 3.67-13.6), while no association was reported among non-drinkers (OR = 1.31; 95% CI = 0.70-2.47) (116) . The ALDH2 variant has a key role in modulating exposure to acetaldehyde and OSCC risk, but the association seems to be dependent on alcohol consumption status. The reduced clearance of acetaldehyde associated with the inactive ALDH2*2 allele leads to higher levels of circulating acetaldehyde following alcohol intake, which results in higher risk of OSCC compared to carriers of the ALDH1*1 allele. However, the high blood acetaldehyde levels post alcohol intake leads to alcohol flush reaction and reluctance to alcohol consumption, which may override the observed positive association between the ALDH2*2 allele and OSCC risk. The dual action of the ALDH2 polymorphism on acetaldehyde metabolism and alcohol consumption behaviour renders its use as a proxy of alcohol exposure challenging in Mendelian randomization studies (114) .
Mendelian randomization offers a powerful approach to investigate the role of lifestyle exposure on the occurrence of specific diseases by reducing the influence of confounding, reverse causation and exposure misclassification on estimated associations. However, in the context of genetic variants regulating enzymes that control circulating acetaldehyde, findings from Mendelian randomization should be integrated with information from reported measurements of alcohol intake (116) .
Mechanisms of alcohol-gene interactions in OC
A biological explanation of the variable association between ALDH2*2 (rs671) and OSCC risk by alcohol drinking status has been offered. Individuals carrying the ALDH2*2/*2 homozygous genotype lack ALDH activity, resulting in the accumulation of acetaldehyde in tissues following alcohol intake (117, 118) . These subjects may develop alcohol flush reaction and reluctance to alcohol consumption, thus resulting in a lower risk of developing alcoholinduced OSCC compared with ALDH2*1/*1 carriers (119). As for individuals carrying the ALDH2*1/*2 heterozygous genotype, their reduced capacity to remove acetaldehyde will not prevent them from alcohol use, yet making them exposed to acetaldehyde for a longer time window compared to carriers of the most functional genotype (ALDH2*1/*1) (119). This would explain the higher risk of OSCC associated with ALDH2*1/*2 heterozygosity compared with the ALDH2*1/*1 genotype (120). A similar mechanism of carcinogenesis has been proposed for the ADH1B gene polymorphism. The high-activity ADH1B*2 allele (rs1229984) leads to alcohol flushing due to the accumulation of acetaldehyde in tissues following alcohol intake (119, 121) , while alcohol drinkers with the less active ADH1B*1/*1 genotype may produce more manageable amounts of acetaldehyde that would result in enhanced propensity to alcohol consumption and increased risk of developing OSCC (120) . The diminished flush response in alcohol drinkers associated with the ADH1B*1/*1 genotype may increase the carcinogenic effect of ALDH2*1/*2 heterozygosity on the oesophagus. Thus, individuals carrying both risk genotypes are likely to be exposed to higher levels of acetaldehyde due to increased alcohol consumption (ADH1B*1/*1) and delayed acetaldehyde clearance (ALDH2*1/*2). This hypothesis is supported by findings from epidemiological studies where ADH1B*1/*1 and ALDH2*1/*2 act in a multiplicative fashion on the occurrence of OSCC, especially among heavy alcohol drinkers (95, 96, 100, 106, 122) .
ADH1B is the main enzyme among class I ADHs expressed in the oesophagus (123) . Higher acetaldehyde concentrations were reported in the saliva of Japanese alcoholics carrying the ADH1B*1/*1 homozygous genotype compared with carriers of the ADH1B*2 allele as a result of oral microbial oxidation of ethanol (124) (125) (126) . On the other hand, the oesophagus lacks ALDH2 activity or expresses it extremely weakly, if at all (123) . Thus, the enhanced OSCC risk associated with the ALDH2*1/*2 genotype among alcohol drinkers may be partially mediated by the increasing local accumulation of acetaldehyde due to inefficient elimination of this metabolite. These findings indicate that the effects of genetic polymorphisms on acetaldehyde exposure are key components in the development of alcohol-related OSCC.
Discussion and conclusions
Dose-response relationships between alcohol intake and OSCC risk have been consistently reported in regions with the low and high incidence of the disease, with excess risks mostly apparent among heavy drinkers. In the absence of tobacco smoking, the association between alcohol and the risk of OSCC is weaker; similar conclusions were reported for upper aerodigestive tract cancer in a prospective study of UK women (36) and a pooled analysis of 15 case-control studies (45) . Alcohol may accentuate the known adverse effect of smoking on oesophageal carcinogenesis (15) through several plausible mechanisms, such as promoting the absorption or the metabolism of tobacco-derived carcinogens. An increased risk of OSCC among non-drinkers compared to low drinkers has also been reported (36) , suggesting a potential non-linear association between alcohol drinking and the risk of this malignancy. However, using baseline nondrinkers as the reference category in such analysis entails challenges related to exposure misclassification, reverse causality and the presence of former alcohol drinkers (127) .
The aetiological evaluation of OC with respect to alcohol intake is characterized by several challenging aspects. These include analytical choices of the reference category, with or without the inclusion of non-consumers in the reference category, the opportunity of capturing non-linear dose-response association, and the handling of study populations with very heterogeneous consumption patterns. These challenges are exacerbated by the methodological limitations related to the use of dietary questionnaires, such as reporting bias and incomplete food tables (128) , as well as the exposure to unknown environmental factors that could interfere with alcohol metabolism and absorption (129) . To overcome these limitations, biomarkers of exposure may offer a more accurate estimation of alcohol intake (130) , and several alcohol metabolites hold promise to objectively assess more reliable associations between alcohol exposure and OSCC risk in future epidemiological studies (131, 132) .
The ADH1B, ADH1C and ALDH2 gene polymorphisms influence the risk of OSCC through modulation of acetaldehyde exposure and sensitivity to alcohol flush reaction. Candidate gene studies have found a significantly increased risk associated with either ADH1B*1/*1 or ALDH2*2 among alcohol drinkers, while findings on the relationship between ADH1C*2 and OSCC risk are inconsistent. The GWAS approach has overtaken the limitations of candidate gene studies, and novel genetic variants on chromosome 4q21-23 (ADH) and 12q24 (ALDH) have been associated with the risk of OSCC in both Asian and European populations. Since nearby ADH and ALDH gene variants are inherited together as haplotypes, the associated variants may not have a causal effect, but merely be in LD with the undetected causal variants. Furthermore, differences in LD patterns across ethnicities imply that the effect of genetic variants on cancer risk observed in one population may not be observed in other populations. Follow-up fine-mapping and functional studies are warranted to evaluate the potential biological effect of the SNPs on enzyme activity, alcohol metabolism and the development of OSCC. Novel findings in this direction would allow the discovery of novel susceptibility variants that could potentially be used to estimate the causal role of alcohol intake through Mendelian randomization.
Although the GWAS approach has unveiled many SNPs associated with OSCC, there might be yet unidentified risk loci that could influence greatly the risk of the disease through changes in alcohol metabolism. In contrast to common genetic variants, rare variants are not tagged by conventional genome-wide genotyping arrays, while GWAS may be underpowered to detect associations with low-frequency variants. This gap could be filled by rare variant association studies that make use of assays and analytic techniques, such as novel exome arrays, to identify rare genetic variants (133) .
Recent epidemiological and experimental data have suggested the microbiome as new a promising avenue for research in alcohol-related oesophageal carcinogenesis, which may provide insight into alternative mechanisms beyond the carcinogenic effects of acetaldehyde. However, epidemiological studies on the association between gastrointestinal microbiota and OC risk still very few, typically with small sample size and cross-sectional design. Large prospective studies are the next logical step to evaluate the causal relationship between alcohol intake, microbial communities and OC risk in populations with different dietary and genetic settings. Experimental studies can also prove useful to establish causality, while the use of germ-free animal models inoculated with single or groups of bacteria can provide clues to understand the role of specific bacteria in alcohol-induced OC. Future studies should also incorporate the study of fungi, protists and viruses, in addition to bacteria and archaea, to fully characterize the human microbiome and its relationship with OC risk. Finally, -omics approaches such as transcriptomic and metabolomic are needed to acquire relevant information on microbiota function and the way alcohol exerts its carcinogenic role (134) .
Growing evidence shows that epigenetic changes, such as aberrant DNA methylation, play an important role in the initiation and progression of both OC subtypes. In addition, tobacco and alcohol use were found to be associated with DNA methylation changes in OSCC tissues. The epigenetic characterization of OC is still in its infancy, and most studies have focused on selected genes with a limited number of CpG loci. Genome-wide methylation studies offer a valid instrument to define the DNA methylation landscape associated with alcohol exposure and oesophageal carcinogenesis.
At present, there are no biomarkers for early detection of OC, and we are far from having a full understanding of the biological mechanisms that drive alcohol-related oesophageal carcinogenesis. Further investigation into promising areas of research is needed to discover new genetic determinants of alcohol-related OC that could be used to develop biomarkers for early detection. Since alcohol consumption is a modifiable factor, findings from these studies could also be used to promote changes in alcohol consumption behaviour and reduce the incidence of the disease in the general population.
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